IVERIC bio, Inc. Revenue
IVERIC bio, Inc. reported Revenue of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-02-27
- IVERIC bio, Inc. revenues for the quarter ending 2018-12-31 was $0.00.
- IVERIC bio, Inc. revenues for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- IVERIC bio, Inc. revenues for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- IVERIC bio, Inc. revenues for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- IVERIC bio, Inc. revenues for fiscal 2019 was $0.00.
- IVERIC bio, Inc. revenues for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- IVERIC bio, Inc. revenues for fiscal 2017 was $209.98M, a 312.46% increase from fiscal 2016.
- IVERIC bio, Inc. revenues for fiscal 2016 was $50.91M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2020-02-27 |
| 2018-09-30 | $0.00 10-K · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 10-Q · filed 2018-11-02 | $0.00 derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-06-30 | $0.00 10-K · filed 2019-02-28 | $0.00 10-Q · filed 2018-08-01 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $206.65M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-03-31 | $0.00 10-K · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $206.65M derived: sum of 3 quarters · filed 2019-02-28 | $208.31M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 | $206.65M derived: sum of 2 quarters · filed 2019-02-28 | $208.31M derived: sum of 3 quarters · filed 2019-02-28 | $209.98M 10-K · filed 2020-02-27 |
| 2017-09-30 | $206.65M 10-K · filed 2019-02-28 | $208.31M derived: sum of 2 quarters · filed 2019-02-28 | $209.98M 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $1.66M 10-K · filed 2019-02-28 | $3.32M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $1.66M 10-K · filed 2019-02-28 | |||
| 2016-12-31 | $50.91M 10-K · filed 2019-02-28 |